Related Experiment Video

Updated: Jun 28, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Carotid stenting: the preferred management for carotid atherosclerosis?

Vivek Rajagopal1, Jay S Yadav

  • 1Cleveland Clinic Foundation, Department of Cardiovascular Medicine, Cleveland, Ohio 44195, USA.

Indian Heart Journal
|November 8, 2008
PubMed

Insights

Carotid artery stenting is emerging as a viable alternative to carotid endarterectomy for managing carotid atherosclerosis. Advances in embolic protection devices are improving its safety and efficacy.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Surgery

Background:

  • Cerebrovascular diseases pose significant global health challenges and economic burdens.
  • Carotid atherosclerosis is a major risk factor for stroke.
  • Carotid endarterectomy has been the standard treatment, but new interventions are emerging.

Purpose of the Study:

  • To review the current evidence on carotid artery stenting (CAS).
  • To compare CAS with carotid endarterectomy (CEA).
  • To discuss the limitations and future directions of CAS.

Main Methods:

  • Review of recent clinical trials and studies comparing CAS and CEA.
  • Analysis of data on procedural outcomes, stroke rates, and mortality.
  • Evaluation of the impact of embolic protection devices in CAS.

Main Results:

  • CAS, particularly with advanced embolic protection, shows comparable or improved outcomes to CEA in select patient groups.
  • Emerging data suggest CAS may become a preferred revascularization strategy.
  • Limitations include the need for further long-term data and standardized protocols.

Conclusions:

  • Carotid artery stenting is a promising alternative to carotid endarterectomy.
  • Technological advancements, especially in embolic protection, are enhancing CAS safety.
  • Further research is needed to define optimal patient selection and long-term efficacy.

More Related Videos

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...